Profile avatar
tiansterzhangmd.bsky.social
I treat & research GU cancers @UTSW in Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Posts=my opinions ASCO COI: https://coi.asco.org/share/3UF-6U3Z/Tian%20Zhang
40 posts 1,489 followers 225 following
Prolific Poster
Conversation Starter
Posts 30 Comments 14

@erplimackmd.bsky.social with killer discussion setting the scene for the #NIAGARA “sandwich” & #Checkmate274, both practice changing for our pts w #bladdercancer. @ascocancer.bsky.social #GU25

submitted 17 days ago • 1 comment

#MattGalsky updating results of #NIAGARA - great to see pathologic complete responses from neoadj gem-cis-durvalumab — durva improves disease free & overall survival even in those w pathCR. @ascocancer.bsky.social #GU25

submitted 17 days ago • 0 comments

#MattMilowsky with updated #Checkmate274 trial - adjuvant nivolumab after cystectomy improves time to recurrence & overall survival in #bladdercancer. Sets up ongoing #Alliance #MODERN trial! @ascocancer.bsky.social #GU25

submitted 17 days ago • 0 comments

Mevrometostat with enzalutamide vs enza alone with nice PSA responses and good PFS benefit! @ascocancer.bsky.social #GU25

submitted 18 days ago • 0 comments

#TanyaDorff w always thoughtful w discussion for metastatic #prostatecancer — buckets of treatments - doublets, triplets, XRT, including trials! #TRIPLESWITCH, #ADREAM, S1802, & more! @ascocancer.bsky.social #GU25

submitted 18 days ago • 0 comments

#EdwinPosadasMD with eloquent discussion on prostatectomy vs surgery, importance of the #PORTOS biomarker to help define radiation benefit. @ascocancer.bsky.social #GU25

submitted 18 days ago • 0 comments

#NeerajAggarwal presents final overall survival from #TALAPRO2 trial - patients w metastatic #prostatecancer lived longer and had improved time to chemo. Only 2 MDS/AML events in entire trial. Supporting the talazoparib-enzalutamide approval. #GU25 @ascocancer.bsky.social

submitted 18 days ago • 1 comment

George Zhao presents PORTOS score and modeling radiation outcomes. Important to help select patients likely to benefit from XRT. @ascocancer.bsky.social #GU25

submitted 18 days ago • 0 comments

Tribute to @felixfengmd - Feng Symposium kicks off w @HimanshuNagarMD @mishabeltran @ASCO President-elect #EricSmall at the helm. Announcing the endowed @ASCO YIA, fostering future scientists and science in #prostatecancer. We miss you Felix. Love to @MaryFengMD & family today.

submitted 19 days ago • 0 comments

Our latest paper on circulating immune biomarkers for metastatic kidney cancer - Tian Zhang @tiansterzhangmd.bsky.social oncodaily.com/insight/tian... #KidneyCancer #OncoDaily #Oncology #Medicine #Health #Cancer

submitted 30 days ago • 0 comments

#UTSouthwestern #SimmonsCancerCenter raising community awareness for #prostatecancer this AM - screening “The Silent Killer: Prostate Cancer in the AA Community” — packed room at Light of the World church. Thanks Director #LandiMaduro for coming! m.imdb.com/title/tt3437...

submitted 30 days ago • 1 comment

At #AUC3 this A.M. discussing what’s next for treatment of NMIBC and treatment of variant histology UC - Gopa Iyer and Josh Meeks chairing session this AM with talks from Andrea Necchi, Michiel Van der Heijden, and Roger Li #bladdercancer

submitted 38 days ago • 1 comment

This GU oncology family — wonderful first #AUC3 consensus conference! @drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social

submitted 39 days ago • 0 comments

Creating a bladder & kidney cancer starter pack of friends and colleagues here in @bsky.app! Please comment if you want to be added! bsky.app/start/did:pl... @pgrivasmdphd.bsky.social @drchoueiri.bsky.social @erplimackmd.bsky.social @davidaggen.bsky.social @pcvblack.bsky.social

submitted 39 days ago • 6 comments

Awesome panel moderated by #MontyPal #BradMcGregor for non clear cell #Kidneycancer. Histology matters! And so do molecular markers! #AUC3 @drchoueiri.bsky.social @pgrivasmdphd.bsky.social @davidaggen.bsky.social @erplimackmd.bsky.social

submitted 39 days ago • 0 comments

#BrianRini & #MikeAtkins debate refractory #kidneycancer management after IO front line or adjuvant PD1 inhibitor. Do we rechallenge? Yes likely after a certain time point (6 vs 12 months debated). #AUC3

submitted 39 days ago • 0 comments

Drs. #NaomiHaas #HansHammers debate locally advanced #kidneycancer and use of periop immunotherapy. Grading, staging, and prediction of risk/benefit leads to rigorous shared decision making with our patients. @drchoueiri.bsky.social #AUC3

submitted 39 days ago • 0 comments

Temporary halt or are we witnessing the start of an anti-science movement? I hope only temporary. Science and medicine and the search for truth are fundamental to helping our patients live longer.

submitted 39 days ago • 1 comment

#BrianShuch kicks us off, local #kidneycancer heterogeneous - guppies, goldfish and sharks! Integrating staging & biomarkers to help us evaluate risk and prognosis. #AUC3

submitted 39 days ago • 0 comments

Launching #AUC3 in Miami, consensus across kidney and bladder cancers. From small steps to significant scientific advances that change our patients’ lives. @drchoueiri.bsky.social #MontyPal #RanaMcKay #JonathanRosenberg

submitted 39 days ago • 1 comment

This Christmas and every year I remember my current and past patients with ornaments on our tree. Have been fortunate to care for thousands in my ten year career in oncology. Hope to help thousands more in the years to come. 🎄🕯️

submitted 68 days ago • 0 comments

Huge kudos to the NCCN for officially incorporating prostate cancer into the Genetic/Familial High-Risk Assessment Guidelines. We've come a long way!

submitted 83 days ago • 0 comments

Redefining first-line options for advanced urothelial carcinoma! Insights on platinum chemotherapy, immunotherapy combos, and patient-tailored strategies. @tiansterzhangmd.bsky.social @oncoalert.bsky.social @oncbrothers.bsky.social #Oncology #BladderCancer

submitted 84 days ago • 0 comments

From @utswinternalmed.bsky.social CME to #GrandRoundsinUrology in the same day! #YairLotan discussed #bladdercancer biomarkers & #ShilpaGupta on sequential treatments in metastatic disease.

submitted 86 days ago • 0 comments

Super charged CME event @utswinternalmed.bsky.social #UTSWCancer #YearinReview 2024! Awesome turnout. Was pleased to highlight all the updates in #kidneycancer #bladdercancer in 15 mins!

submitted 86 days ago • 0 comments

Thanks for highlighting @oncodaily.bsky.social! Was special to do this w my friend from fellowship @erikahamilton9.bsky.social and appreciate the @oncbrothers.bsky.social for hosting us!!

submitted 86 days ago • 0 comments

Working on our #ASCO abstracts already. Deadline Jan 28th! No doubt will be another wave of clinical oncology progress at the annual meeting in 2025!

submitted 100 days ago • 0 comments

@smreddymd.bsky.social highlights immunotherapy for #breastcancer at @utswinternalmed.bsky.social grand rounds. Our #UTSWCancer breast cancer team is strong!

submitted 101 days ago • 0 comments

#Prostatecancer starter pack! Thanks for creating it @ravimadan.bsky.social & including me! Totally here for the prostate cancer knowledge & networks.

submitted 101 days ago • 0 comments

New here — always in search of a challenge and blue skies. Loved the #MedTwitter/#OncTwitter community and hoping the #MedBlueSkies community will be just as good!

submitted 113 days ago • 0 comments